Here, using synthetic lethality screening, we detected and validated three FDA-approved drugs, Tranilast, Telmisartan, and Amphotericin B, which promote Pt-mediated death in ovarian cancer cells, whose resistance to cisplatin relies on ATP7B in a significant manner. The gene discussed is ATP7B; the disease is ovarian cancer.